- PR Newswire•16 days ago
Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult "Ground-state" Stem Cell Technology
MINNEAPOLIS, March 7, 2017 /PRNewswire/ -- Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating, and differentiating adult "ground-state" stem cells from healthy and diseased epithelial tissues. Working together, Bio-Techne and MCT will transition this breakthrough technology into reagents and model systems that will be made available under this license to the research community, enabling scientists to create ex vivo models of epithelial organs in their own laboratories using tissue-specific adult stem cells.
- PR Newswire•22 days ago
MINNEAPOLIS, March 1, 2017 /PRNewswire/ -- Bio-Techne Corporation has partnered with Brazil-based DK Diagnostics to release its first diagnostic tool for the veterinary market. The PARATEST system is an innovative parasitological system which contains the only non-toxic, biodegradable fixative available to the market. The PARATEST system will be manufactured at Bio-Techne's Diagnostic Division in Devens, MA site and leverages its state-of-art formulation, manufacturing, and packaging capabilities to bring this unique solution to companion animals and their owners. In what is expected to become the new standard, this innovative system is uniquely eco-friendly, provides highly accurate results in less time than existing tests, and can be easily performed in the veterinarian's office without special equipment or training. The PARATEST system can test for a wide range of common parasites that companion animals can be infected by in all climates and geographies and helps ensure an accurate diagnosis to start the appropriate treatment quickly.
- Zacks•last month
Options traders are pricing in a big move for Bio-Techne (TECH) shares as it has huge implied volatility.
TECH : Summary for Bio-Techne Corp - Yahoo Finance
Bio-Techne Corporation (TECH)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||103.57 x 100|
|Ask||103.78 x 100|
|Day's Range||102.17 - 103.82|
|52 Week Range||91.45 - 117.42|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||49.29|
|Dividend & Yield||1.28 (1.25%)|
|1y Target Est||N/A|